|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jordan VC: The role of tamoxifen in the
treatment and prevention of breast cancer. Curr Probl Cancer.
16:129–176. 1992.PubMed/NCBI
|
|
3
|
Buzdar A and Howell A: Advances in
aromatase inhibition: Clinical efficacy and tolerability in the
treatment of breast cancer. Clin Cancer Res. 7:2620–2635.
2001.PubMed/NCBI
|
|
4
|
Romond EH, Perez EA, Bryant J, Suman VJ,
Geyer CE Jr, Davidson NE, Tan-Chiu E, Martino S, Paik S, Kaufman
PA, et al: Trastuzumab plus adjuvant chemotherapy for operable
HER2-positive breast cancer. N Engl J Med. 353:1673–1684. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dent R, Hanna WM, Trudeau M, Rawlinson E,
Sun P and Narod SA: Pattern of metastatic spread in triple-negative
breast cancer. Breast Cancer Res Treat. 115:423–428. 2009.
View Article : Google Scholar
|
|
6
|
Brenton JD, Carey LA, Ahmed AA and Caldas
C: Molecular classification and molecular forecasting of breast
cancer: Ready for clinical application? J Clin Oncol. 23:7350–7360.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cancer Genome Atlas Network: Comprehensive
molecular portraits of human breast tumours. Nature. 490:61–70.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qi X, Yin N, Ma S, Lepp A, Tang J, Jing W,
Johnson B, Dwinell MB, Chitambar CR and Chen G: p38γ MAPK is a
therapeutic target for triple-negative breast cancer by stimulation
of cancer stem-like cell expansion. Stem Cells. 33:2738–2747. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakshatri H, Bhat-Nakshatri P, Martin DA,
Goulet RJ Jr and Sledge GW Jr: Constitutive activation of NF-kappaB
during progression of breast cancer to hormone-independent growth.
Mol Cell Biol. 17:3629–3639. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sero JE, Sailem HZ, Ardy RC, Almuttaqi H,
Zhang T and Bakal C: Cell shape and the microenvironment regulate
nuclear translocation of NF-κB in breast epithelial and tumor
cells. Mol Syst Biol. 11:7902015. View Article : Google Scholar
|
|
11
|
Khoshnan A, Tindell C, Laux I, Bae D,
Bennett B and Nel AE: The NF-kappa B cascade is important in Bcl-xL
expression and for the anti-apoptotic effects of the CD28 receptor
in primary human CD4+ lymphocytes. J Immunol.
165:1743–1754. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang CY, Mayo MW, Korneluk RG, Goeddel DV
and Baldwin AS Jr: NF-kappaB antiapoptosis: Induction of TRAF1 and
TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation.
Science. 281:1680–1683. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huber MA, Azoitei N, Baumann B, Grünert S,
Sommer A, Pehamberger H, Kraut N, Beug H and Wirth T: NF-kappaB is
essential for epithelial-mesenchymal transition and metastasis in a
model of breast cancer progression. J Clin Invest. 114:569–581.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hartman ZC, Poage GM, den Hollander P,
Tsimelzon A, Hill J, Panupinthu N, Zhang Y, Mazumdar A, Hilsenbeck
SG, Mills GB, et al: Growth of triple-negative breast cancer cells
relies upon coordinate autocrine expression of the proinflammatory
cytokines IL-6 and IL-8. Cancer Res. 73:3470–3480. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hinz M, Krappmann D, Eichten A, Heder A,
Scheidereit C and Strauss M: NF-kappaB function in growth control:
Regulation of cyclin D1 expression and G0/G1-to-S-phase transition.
Mol Cell Biol. 19:2690–2698. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yousef EM, Tahir MR, St-Pierre Y and
Gaboury LA: MMP-9 expression varies according to molecular subtypes
of breast cancer. BMC Cancer. 14:6092014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kagoya Y, Yoshimi A, Kataoka K, Nakagawa
M, Kumano K, Arai S, Kobayashi H, Saito T, Iwakura Y and Kurokawa
M: Positive feedback between NF-κB and TNF-α promotes
leukemia-initiating cell capacity. J Clin Invest. 124:528–542.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gill PS, Rarick M, McCutchan JA, Slater L,
Parker B, Muchmore E, Bernstein-Singer M, Akil B, Espina BM, Krailo
M, et al: Systemic treatment of AIDS-related Kaposi's sarcoma:
Results of a randomized trial. Am J Med. 90:427–433. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Saville MW, Lietzau J, Pluda JM,
Feuerstein I, Odom J, Wilson WH, Humphrey RW, Feigal E, Steinberg
SM, Broder S, et al: Treatment of HIV-associated Kaposi's sarcoma
with paclitaxel. Lancet. 346:26–28. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ahmad A, Banerjee S, Wang Z, Kong D and
Sarkar FH: Plumbagin-induced apoptosis of human breast cancer cells
is mediated by inactivation of NF-kappaB and Bcl-2. J Cell Biochem.
105:1461–1471. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jin ML, Park SY, Kim YH, Park G and Lee
SJ: Halofuginone induces the apoptosis of breast cancer cells and
inhibits migration via downregulation of matrix
metalloproteinase-9. Int J Oncol. 44:309–318. 2014. View Article : Google Scholar
|
|
22
|
Pozo-Guisado E, Merino JM, Mulero-Navar ro
S, Lorenzo-Benayas MJ, Centeno F, Alvarez-Barrientos A and
Fernandez-Salguero PM: Resveratrol-induced apoptosis in MCF-7 human
breast cancer cells involves a caspase-independent mechanism with
downregulation of Bcl-2 and NF-kappaB. Int J Cancer. 115:74–84.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Singh S and Aggarwal BB: Activation of
transcription factor NF-kappa B is suppressed by curcumin
(diferuloylmethane) [corrected]. J Biol Chem. 270:24995–25000.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tse AK, Wan CK, Shen XL, Yang M and Fong
WF: Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and
NF-kappaB-regulated gene expression through suppression of IKK
activation. Biochem Pharmacol. 70:1443–1457. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen KS, Shi MD, Chien CS and Shih YW:
Pinocembrin suppresses TGF-β1-induced epithelial-mesenchymal
transition and metastasis of human Y-79 retinoblastoma cells
through inactivating αvβ3 integrin/FAK/p38α signaling pathway. Cell
Biosci. 4:412014. View Article : Google Scholar
|
|
26
|
Pascual ME, Slowing K, Carretero E,
Sánchez Mata D and Villar A: Lippia: traditional uses, chemistry
and pharmacology: a review. J Ethnopharmacol. 76:201–214. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Stashenko EE, Martínez JR, Ruíz CA, Arias
G, Durán C, Salgar W and Cala M: Lippia origanoides chemotype
differentiation based on essential oil GC-MS and principal
component analysis. J Sep Sci. 33:93–103. 2010. View Article : Google Scholar
|
|
28
|
Stashenko EE, Martínez JR, Cala MP, Durán
DC and Caballero D: Chromatographic and mass spectrometric
characterization of essential oils and extracts from Lippia
(Verbenaceae) aromatic plants. J Sep Sci. 36:192–202. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Legault J and Pichette A: Potentiating
effect of beta-caryophyllene on anticancer activity of
alpha-humulene, isocaryophyllene and paclitaxel. J Pharm Pharmacol.
59:1643–1647. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Aristatile B, Al-Assaf AH and Pugalendi
KV: Carvacrol suppresses the expression of inflammatory marker
genes in D-galactosamine-hepatotoxic rats. Asian Pac J Trop Med.
6:205–211. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Greiner JF, Müller J, Zeuner MT, Hauser S,
Seidel T, Klenke C, Grunwald LM, Schomann T, Widera D, Sudhoff H,
et al: 1,8-Cineol inhibits nuclear translocation of NF-κB p65 and
NF-κB-dependent transcriptional activity. Biochim Biophys Acta.
1833:2866–2878. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee JC, Kundu JK, Hwang DM, Na HK and Surh
YJ: Humulone inhibits phorbol ester-induced COX-2 expression in
mouse skin by blocking activation of NF-kappaB and AP-1: IkappaB
kinase and c-Jun-N-terminal kinase as respective potential upstream
targets. Carcinogenesis. 28:1491–1498. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liang D, Li F, Fu Y, Cao Y, Song X, Wang
T, Wang W, Guo M, Zhou E, Li D, et al: Thymol inhibits
LPS-stimulated inflammatory response via down-regulation of NF-κB
and MAPK signaling pathways in mouse mammary epithelial cells.
Inflammation. 37:214–222. 2014. View Article : Google Scholar
|
|
34
|
Kim C, Cho SK, Kim KD, Nam D, Chung WS,
Jang HJ, Lee SG, Shim BS, Sethi G and Ahn KS: β-Caryophyllene oxide
potentiates TNFα-induced apoptosis and inhibits invasion through
down-modulation of NF-κB-regulated gene products. Apoptosis.
19:708–718. 2014. View Article : Google Scholar
|
|
35
|
Schneider CA, Rasband WS and Eliceiri KW:
NIH Image to ImageJ: 25 years of image analysis. Nat Methods.
9:671–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Portt L, Norman G, Clapp C, Greenwood M
and Greenwood MT: Anti-apoptosis and cell survival: A review.
Biochim Biophys Acta. 1813:238–259. 2011. View Article : Google Scholar
|
|
37
|
Baldin V, Lukas J, Marcote MJ, Pagano M
and Draetta G: Cyclin D1 is a nuclear protein required for cell
cycle progression in G1. Genes Dev. 7:812–821. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Salvesen GS and Duckett CS: IAP proteins:
Blocking the road to death's door. Nat Rev Mol Cell Biol.
3:401–410. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bertrand MJ, Milutinovic S, Dickson KM, Ho
WC, Boudreault A, Durkin J, Gillard JW, Jaquith JB, Morris SJ and
Barker PA: cIAP1 and cIAP2 facilitate cancer cell survival by
functioning as E3 ligases that promote RIP1 ubiquitination. Mol
Cell. 30:689–700. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yamaguchi N, Ito T, Azuma S, Ito E, Honma
R, Yanagisawa Y, Nishikawa A, Kawamura M, Imai J, Watanabe S, et
al: Constitutive activation of nuclear factor-kappaB is
preferentially involved in the proliferation of basal-like subtype
breast cancer cell lines. Cancer Sci. 100:1668–1674. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Grigoriadis A, Mackay A, Noel E, Wu PJ,
Natrajan R, Frankum J, Reis-Filho JS and Tutt A: Molecular
characterisation of cell line models for triple-negative breast
cancers. BMC Genomics. 13:6192012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nguyen A, Yoshida M, Goodarzi H and
Tavazoie SF: Highly variable cancer subpopulations that exhibit
enhanced transcriptome variability and metastatic fitness. Nat
Commun. 7:112462016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Leung E, Kannan N, Krissansen GW, Findlay
MP and Baguley BC: MCF-7 breast cancer cells selected for tamoxifen
resistance acquire new phenotypes differing in DNA content,
phospho-HER2 and PAX2 expression, and rapamycin sensitivity. Cancer
Biol Ther. 9:717–724. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Peter ME and Krammer PH: The
CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 10:26–35. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Beaudouin J, Liesche C, Aschenbrenner S,
Hörner M and Eils R: Caspase-8 cleaves its substrates from the
plasma membrane upon CD95-induced apoptosis. Cell Death Differ.
20:599–610. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yamamoto M, Taguchi Y, Ito-Kureha T, Semba
K, Yamaguchi N and Inoue J: NF-κB non-cell-autonomously regulates
cancer stem cell populations in the basal-like breast cancer
subtype. Nat Commun. 4:22992013. View Article : Google Scholar
|
|
47
|
Micheau O and Tschopp J: Induction of TNF
receptor I-mediated apoptosis via two sequential signaling
complexes. Cell. 114:181–190. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Guttridge DC, Albanese C, Reuther JY,
Pestell RG and Baldwin AS Jr: NF-kappaB controls cell growth and
differentiation through transcriptional regulation of cyclin D1.
Mol Cell Biol. 19:5785–5799. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
You M, Ku PT, Hrdlicková R and Bose HR Jr:
ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is
a mediator of the antiapoptotic activity of the v-Rel oncoprotein.
Mol Cell Biol. 17:7328–7341. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lin Y, Devin A, Rodriguez Y and Liu ZG:
Cleavage of the death domain kinase RIP by caspase-8 prompts
TNF-induced apoptosis. Genes Dev. 13:2514–2526. 1999. View Article : Google Scholar : PubMed/NCBI
|
